Follitropin alfa biosimilar (CinnaGen)

促卵泡激素α生物类似药 (CinnaGen)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFollitropin alfa biosimilar (CinnaGen)

Drug Alias Name促卵泡素α生物仿制药 (CinnaGen)Cinnal-Frec Hu-FSH

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone

Mechanisms of ActionFollicle-stimulating hormone receptor agonistsOvarian follicle stimulants

TargetsFollicle-stimulating hormone receptor

Therapy Area/IndicationsInfertility

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesCinnagen

China Registration ClassN/A

Active CompaniesCinnagen

Inactive CompaniesN/A

Active IndicationsInfertility

Inactive IndicationsN/A

ATC CodeG03GA05